Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [3413]

A potential prognostic biomarker of chemoresistance in mCRC treated with FUFIRI...

Dr Arndt Stahler - University of Munich, Munich, Germany

A potential prognostic biomarker of chemoresistance in mCRC treated with FUFIRI or mIrOx (FIRE1) ( Dr Arndt Stahler - University of Munich, Munich, Germany )

Thousands of melanoma patients in Europe have no access to new drugs

Prof Lidija Kandolf Sekulovic - Military Medical Academy, Belgrade, Serbia

Thousands of melanoma patients in Europe have no access to new drugs ( Prof Lidija Kandolf Sekulovic - Military Medical Academy, Belgrade, Serbia )

Adjuvant cetuximab in the PETACC8 trial for stage III colon cancer

Prof Julien Taïeb - Georges Pompidou European Hospital, Paris, France

Adjuvant cetuximab in the PETACC8 trial for stage III colon cancer ( Prof Julien Taïeb - Georges Pompidou European Hospital, Paris, France )

FALCON trial: fulvestrant vs. anastrozole for HR advanced breast cancer

Prof John Robertson - University of Nottingham, Nottingham, UK

FALCON trial: fulvestrant vs. anastrozole for HR advanced breast cancer ( Prof John Robertson - University of Nottingham, Nottingham, UK )

Dabrafenib shows higher response and lower toxicity in paediatric brain cancer...

Dr Mark Kieran - Dana-Farber/Boston Children’s Cancer and Blood Disorders...

Dabrafenib shows higher response and lower toxicity in paediatric brain cancer trial ( Dr Mark Kieran - Dana-Farber/Boston Children’s Cancer and Blood Disorders Center, Boston, USA )

Ribociclib improves progression-free survival in advanced breast cancer

Prof Gabriel Hortobagyi - University of Texas MD Anderson Cancer Center...

Ribociclib improves progression-free survival in advanced breast cancer ( Prof Gabriel Hortobagyi - University of Texas MD Anderson Cancer Center, Houston, US )

Outcome of ovarian cancer patients was significantly improved with niraparib

Dr Mansoor Raza Mirza - Copenhagen University Hospital, Copenhagen, Denmark

Outcome of ovarian cancer patients was significantly improved with niraparib ( Dr Mansoor Raza Mirza - Copenhagen University Hospital, Copenhagen, Denmark )

Niraparib significantly improves outcomes for ovarian cancer patients

Dr Mansoor Raza Mirza - Rigshospitalet, Copenhagen University Hospital, Denmark

Niraparib significantly improves outcomes for ovarian cancer patients ( Dr Mansoor Raza Mirza - Rigshospitalet, Copenhagen University Hospital, Denmark )

Ipilimumab as adjuvant therapy improves OS in high risk melanoma

Prof Alexander Eggermont - Institut Gustave Roussy, Villejuif, France

Ipilimumab as adjuvant therapy improves OS in high risk melanoma ( Prof Alexander Eggermont - Institut Gustave Roussy, Villejuif, France )

Ribociclib improves PFS for postmenopausal women with hormone receptor-positive...

Dr Gabriel Hortobagyi - MD Anderson, Houston, USA

Ribociclib improves PFS for postmenopausal women with hormone receptor-positive breast cancer ( Dr Gabriel Hortobagyi - MD Anderson, Houston, USA )

Immunotherapy and treatment advances in small cell lung cancer

Prof Dean Fennell - University of Leicester, Leicester, UK

Immunotherapy and treatment advances in small cell lung cancer ( Prof Dean Fennell - University of Leicester, Leicester, UK )

Screening, surgical cure and new developments: Future smart surgical approaches...

Dr Francesco Di Meco - Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan...

Screening, surgical cure and new developments: Future smart surgical approaches for brain mets ( Dr Francesco Di Meco - Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy )

More from ecancer